GSE176127
The Distinct Immune Nature of the Fetal Inflammatory Response Syndrome Type I and Type II
Umbilical cord blood samples from neonates with FIRS type I, FIRS type II, and without FIRS were profiled using paired-end Illumina RNAseq to evaluate transcriptomic changes associated with these syndromes. Overall design: The study included umbilical cord blood from neonates diagnosed with FIRS type I (n = 11), FIRS type II (n = 6), or without FIRS (n = 22) born to women who underwent preterm labor with intact membranes.